Neuralink 注册 PRIME2 新试验：脑机接口帮中风瘫痪者用意念打字
Neuralink 又开了个新试验 PRIME2，这次把中风瘫痪的人也纳入进来了，最多招 10 个成年人，在迈阿密大学招募。用的还是 N1 植入物加 R1 手术机器人，让人靠意念控制光标打字。家里有中风、渐冻症或脊髓损伤患者的可以关注下招募信息。
Neuralink 已注册一项名为 PRIME2 的新脑机接口临床试验，首次纳入因缺血性中风导致长期瘫痪的患者。试验计划招募最多 10 名成年参与者，涵盖因缺血性中风、脊髓损伤或 ALS（渐冻症）导致手臂和手部严重无力的人群，迈阿密大学被列为招募站点。
试验将使用 Neuralink 的 N1 大脑植入物和 R1 手术机器人，目标是让参与者仅凭意念就能移动电脑光标并进行打字操作。此前 Neuralink 的试验主要面向脊髓损伤患者，PRIME2 把适用范围扩展到中风患者——中风是全球范围内导致长期瘫痪的主要原因之一，这一扩展直接扩大了潜在适用人群。
对脑机接口领域而言，注册新试验意味着从验证安全性与基础功能，转向覆盖更多病因类型的临床场景；对中风后长期瘫痪的患者家庭来说，也多了一条参与前沿疗法的正规渠道。
Neuralink has registered PRIME2, a new brain implant trial that includes people with lasting paralysis from strokes caused by blocked blood vessels.
Enrollment is open for up to 10 adults with severe arm and hand weakness from these strokes, spinal cord injuries or ALS. The University of Miami is listed as a recruiting site.
The study will test Neuralink’s N1 brain implant and R1 surgical robot to help participants move a computer cursor and type using only their thoughts.
Another step toward helping more people regain independence. ♥️
This report is categorized under AITOP's "Industry" desk, focusing on US frontier AI labs and Silicon Valley technology leaders. Key entities and technical topics under continuous tracking include Neuralink, 脑机接口, PRIME2, ALS.
Source attribution: curated from @cb_doge (@cb_doge).
